This paper is in the following e-collection/theme issue:

Clinical Cancer Research (73) Policy and Policy Proposals (115) Recruitment of Research Participants (280) Health Services Research in Oncology (29) Research Infrastructures and Registries (45) Secondary Use of Clinical Data for Research and Surveillance (326) Demographics of Users, Social & Digital Divide (685) Vulnerable Populations in Health Research (65)

Published on in Vol 8, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33240, first published .
Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants

Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants

Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants

Authors of this article:

Dinesh Pal Mudaranthakam1 Author Orcid Image ;   Byron Gajewski1 Author Orcid Image ;   Hope Krebill1 Author Orcid Image ;   James Coulter1 Author Orcid Image ;   Michelle Springer1 Author Orcid Image ;   Elizabeth Calhoun1 Author Orcid Image ;   Dorothy Hughes1 Author Orcid Image ;   Matthew Mayo1 Author Orcid Image ;   Gary Doolittle1 Author Orcid Image
Article Authors Cited by (9) Tweetations (4) Metrics

Journals

  1. Robler S, Coco L, Krumm M. Telehealth solutions for assessing auditory outcomes related to noise and ototoxic exposures in clinic and research. The Journal of the Acoustical Society of America 2022;152(3):1737 View
  2. McIntire R, Keith S, Nowlan T, Butt S, Cambareri K, Callaghan J, Halstead T, Chandrasekar T, Kelly W, Leader A. Predictors of consenting to participate in a clinical trial among urban cancer patients. Contemporary Clinical Trials 2023;125:107061 View
  3. Farris P, Crist R, Miller S, Shannon J. Rural research capacity: a co-created model for research success. Health Research Policy and Systems 2023;21(1) View
  4. Langley B, Talas S, El-Shakankery K, Michie C. Improving Inclusivity, Equity, and Diversity in Oncology Clinical Trials: A European Perspective. EMJ Oncology 2023:68 View
  5. Ring K, Duska L. How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populations. Gynecologic Oncology 2024;184:8 View
  6. Anderson E, DiPalazzo J, Lucas F, Hall M, Antov A, Helbig P, Bourne J, Graham L, Gaitor L, Lu-Emerson C, Bradford L, Inhorn R, Sinclair S, Brooks P, Thomas C, Rasmussen K, Han P, Liu E, Rueter J. Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI). npj Precision Oncology 2024;8(1) View
  7. Lond B, Dodd C, Davey Z, Darlison L, McPhelim J, Rawlinson J, Williamson I, Merriman C, Waddington F, Bagnallainslie D, Rajendran B, Usman J, Henshall C. A systematic review of the barriers and facilitators impacting patient enrolment in clinical trials for lung cancer. European Journal of Oncology Nursing 2024;70:102564 View
  8. Sabesan S, Poxton M. Health equity in clinical trials for regional, rural and First nations communities: Need for networked clinical trial system, through a values and purpose‐aligned system culture. Australian Journal of Rural Health 2024;32(3):588 View
  9. Arana‐Chicas E, Prisco L, Sharma S, Stauffer F, Dauphin S, Ban‐Hoefen M, Navarette J, Zittel J, Cupertino A, Magnuson A, Mustian K, Mohile S. Barriers to participation in clinical trials of rural older adult cancer survivors: A qualitative study. The Journal of Rural Health 2024 View